Global Malignant Mesothelioma Market By Drug Type (Pemetrexed & Combination, Gemcitabine & Combination, Cisplatin & Combination, Carboplatin & Combination, Vinorelbine & Combination and Others), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital Pharmacies, Oncology Centers and Retail Pharmacies), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035
- Published date: Feb 2026
- Report ID: 179751
- Number of Pages: 370
- Format:
-
keyboard_arrow_up
-
-
- Novocure
- Bristol-Myers Squibb
- Merck & Co.
- F. Hoffmann-La Roche
- AstraZeneca
- Eli Lilly and Company
- Pfizer
- Boehringer Ingelheim
- Takeda Pharmaceutical Company
- Amgen
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible


